Jerry Rosenbaum, MD

Co-Founder

Jerry is the Stanley Cobb Professor of Psychiatry at Harvard Medical School and chaired the Massachusetts General Hospital Psychiatry Department for 20 years. He is currently the director of the Center for Neuroscience of Psychedelics to understand how psychedelics change the brain and to explore novel mechanisms for the treatment of psychiatric disorders. He was the 2007 recipient of the C. Charles Burlingame Award for lifetime achievement in psychiatric research and education and the 2016 recipient of the Joseph B. Martin Dean's Leadership Award for the Advancement of Women Faculty for Harvard Medical School. He is Emeritus Fellow of the American College of Neuropsychopharmacology (ACNP). In 2018, he was an Ellis Island Medal of Honor awardee. He was President/Board Chair of the Anxiety and Depression Association of America (ADAA) and served as President and is a Board member of the American Foundation for Suicide Prevention. He served a six-year term as Trustee of the Massachusetts General Hospital and was Trustee of the Partners Healthcare System. He is co-Chair of Development at Mass General. He’s co-authored more than 400 original articles and reviews and edited 20 books. He led longitudinal studies of children at risk for anxiety disorders and depression, which examined behavioral differences, risk factors, longitudinal outcomes, treatment, genetics and brain structure and function of children of parents with mood and anxiety disorders.

Scientific Co-Founders

Team

Senior Director, Head of Computational Biology
Senior Research Associate, Neuroscience
Chief of Staff and Co-Founder
Finance Manager
CEO and Co-Founder
Director, Neurobiology
Associate Director, Finance
Associate Director, R&D Operations
Scientist I, Computational Biology
Director, Drug Discovery
Vice President, Finance
Consultant
Neuroscientist